Skip to main content
Premium Trial:

Request an Annual Quote

Maryland's IGS Lands $20M NIAID Pathogen Sequencing Contract

NEW YORK (GenomeWeb News) – The Institute for Genome Sciences at the University of Maryland has won a $20 million contract from the National Institute of Allergy and Infectious Diseases to create a center for sequencing pathogens such as those that cause infectious diseases or which may be used as bioweapons, the university said today.

The school will use the funding to create a Genomics Sequencing Center for Infectious Diseases, which will generate data that can be used to develop new diagnostic and treatment tools for combating outbreaks of emerging pathogens, such as the 2009 H1N1, SARS, or foodborne illnesses, as well as biothreats.

The terms of the contract encourage IGS to collaborate with other doctors and scientists who have unusual or significant pathogen samples and who can propose sequencing projects. These partners will gain access to the genomic information IGS discovers.

The funding will cover the cost of sequencing and analysis, and will be used to create a library of information that will be shared with other researchers around the country.

"With the help of the next-generation genomic sequencing equipment we have acquired at IGS, this contract will serve as a ready-made funding mechanism that could allow us to sequence as many as 500 to 600 DNA samples in five years," IGS Director and University of Maryland Professor Claire Fraser-Liggett said in a statement.

NIAID drafted the genome centers program to enable centers to respond within days or weeks in the event of a bioterror attack or the outbreak of a foodborne illness. If a foodborne illness occurred, for example, IGS will be able to gain approval quickly for a project to sequence and analyze the organism's genome, according to the university.

"We hope that by accelerating the process of sequencing and analyzing the DNA of these infectious diseases, we can also help speed scientists nationwide toward finding cures or vaccines for diseases that threaten lives in the U.S. and worldwide, such as pandemic influenza," said Fraser-Liggett.

Last week, the J. Craig Venter Institute said that it had landed a $43 million contract from NIAID to support its sequencing activities as one of the Genomic Sequencing Centers for Infectious Diseases.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.